Publications 2004
  1. Morré SA, Ouburg S, Klinkenberg-Knol EC, Mulder CJ, Peña AS.
    The true ligand of the NOD2 receptor is peptidoglycan instead of lipopolysaccharide: a schematic representation of ligand-receptor interactions and NF-kB activation.
    Gastroenterology 2004;126:371-372.
  2. R. K. Linskens, R. C. Mallant-Hent, L. S. Murillo, B. M. E. von Blomberg, B. Z. Alizadeh and A. S. Peña
    Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn's disease population
    Digestive and Liver Disease 2004;36:29-34
  3. AS Peña, JJ Kolkman, R. Greinwald, H-D. Tauschel, FG Nelis, P Viergever, AC Möllmann, G Hochhaus, HW Möllmann
    In : "Proceedings Falk Workshop Berlin, Germany June 14, 2003".Topical Steroids in Gastroenterology and Hepatology.
    Eds. A Dignass, V Gross, HJ Nuhr, OFW James. Kluwer Academic Publishers. Dordrecht, Boston 2004;pp 30-35.
  4. Jing Wu, BZ Alizadeh, TV Veen, JWR Meijer, CJJ Mulder, AS Peña
    Association of FAS (TNFRSF6)-670 gene polymorphism with villous atrophy in coeliac disease
    World J Gastroenterol 2004;10(5):717-720
  5. Núñez C, Barreiro M, Domínguez-Muñoz JE, Lorenzo A, Zapata C, and Peña AS
    CARD15 Mutations in Patients With Crohn's Disease in a Homogeneous Spanish Population
    American Journal of Gastroenterology 2004;99:450-6.
  6. Laine ML, Murillo LS, Morré SA, van Dijk LJ, Ham AJ, Winkel EG, Peña AS, van Winkelhoff AJ.
    CARD15 gene mutations in adult periodontitis
    Journal of Clinical Periodontology 2004;31(10):890-3.
  7. van Valkengoed IGM, Morré SA, van den Brule AJC, Meijer CJLM, Bouter LM, Boeke AJP.
    Overestimation of Complication-rates of Chlamydia trachomatis Screening programmes: implications for cost-effectiveness analyses.
    International Journal of Epidemiology 2004. 33: 416-425.
  8. Spaargaren J, Verhaest I, Mooij, SSmit C, Fennema H,  Coutinho RA, Peña AS, Morré SA.
    Analysis of Chlamydia trachomatis serovar distribution changes in the Netherlands (1986-2002).
    Sex Transm Infect. 2004 Apr;80(2):151-152.
  9. Seegers D, Peña AS, Bouma G.
    Capita Selecta. Het auto-immuun lymphoproliferatief syndroom: een stoornis in de geprogrammeerde celdood
    Ned Tijdschr Geneeskd 2004; 148; 371-6
  10. Van Belzen MJ, Koeleman BP, Crusius JB, Meijer JW, Bardoel AF, Pearson PL, Sandkuijl LA, Houwen RH, Wijmenga C.
    Defining the contribution of the HLA region to cis DQ2-positive coeliac disease patients.
    Genes Immun 2004;5(3):215-220.
  11. Van Belzen MJ, Vrolijk MM, Meijer JWR, Crusius JBA, Pearson PL, Sandkuijl LA, Houwen RHJ, Wijmenga C.
    A genomewide screen in a four-generation Dutch family with celiac disease: evidence for linkage to chromosomes 6 and 9.
    Am J Gastroenterol 2004;99(3):466-471.
  12. Schrijver HM, Hooper-van Veen T, van Belzen MJ, Crusius JBA, Peña AS, Barkhof F, Polman CH, Uitdehaag BMJ.
    Polymorphisms in the genes encoding interferon-gamma and interferon-gamma receptors in multiple sclerosis.
    Eur J Immunogenet 2004;31(3):133-140.
  13. Molano M, Meijer CJLM , Morré SA,Pol R. ,van den Brule AJC .
    Combination of PCR targeting the VD2 of omp1 and reverse line blot analysis for typing of urogenital Chlamydia trachomatis serovars in cervical scrape specimens.
    J Clin Microbiol 2004;42(7):2935-2939.
  14. Fei BY, Xia B, Deng CS, Xia XQ, Xie M, Crusius JBA, Pena, AS.
    Association of tumor necrosis factor genetic polymorphism with chronic atrophic gastritis and gastric adenocarcinoma in Chinese Han population.
    World J Gastroenterol 2004;10(9):1256-61
  15. Schrijver HM, Crusius JBA, García González MA, Polman CH, Peña AS, Barkhof F, Uitdehaag BMJ.
    Gender-related association between the TGFB1+869 polymorphism and multiple sclerosis.
    J Interferon Cytokine Res 2004; 24(9): 536-542.
  16. Diosdado B, Wapenaar MC, Franke L, Duran KJ, Goerres MJ, Hadithi M, Crusius JBA, Meijer JWR, Duggan DJ, Mulder CJJ, Holstege FCP, Wijmenga C.
    A microarray screen for novel candidate genes in coeliac disease pathogenesis.
    Gut 2004;53(7):944-951.
  17. Kolkman JJ, Möllmann HW, Möllmann AC, Peña AS, Greinwald R, Tauschel HD, Hochhaus G.
    Evaluation of oral budesonide in the treatment of active distal ulcerative colitis.
    Drugs of Today 2004, 40 (7):589-601.
  18. Servaas A Morré, Sander Ouburg, Rosalie Mallant-Hent, J. Bart A. Crusius, Ad A van Bodegraven, Chris J.J. Mulder, Ronald Linskens and A. Salvador Peña.
    E Letter Reply to Franchimont et al.
    Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis
    Gut 2004; 53: 987-992
  19. Cara CJ, Pena AS, Sans M, Rodrigo L, Guerrero-Esteo M, Hinojosa J, Garcia-Paredes J, Guijarro LG.
    Reviewing the mechanism of action of thiopurine drugs: Towards a new paradigm in clinical practice.
    Med Sci Monit 2004;10(11):RA247-254.
  20. Zwiers A, Seegers D, Heijmans R, Koch A, Hampe J, Nikolaus S, Pena AS, Schreiber S, Bouma G.
    Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease.
    Genes Immun. 2004; 5: 675-677;
  21. Bax CJ, Spaargaren J, Oostvogel PM, Trimbos JB, Dörr PJ, Peña AS, Morré SA.
    Chlamydia trachomatis heat shock protein 60 (cHSP60) antibodies in women without and with tubal pathology using a new commercially available assay.
    Sex Transm Infect 2004;80:415-416.
  22. Lyons JM, Ito JI, Morré SA.
    Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of Chlamydia trachomatis mediated pathogenesis?
    J Clin Pathol 2004;57: 657-659.
  23. Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Pena AS, Diaz-Rubio M, de la Concha EG.
    IBD1 and IBD3 determine location of Crohn's Disease in the Spanish population.
    Inflamm Bowel Dis 2004;10(6):715-722.